MedaPhor Group has launched its new BodyWorks Eve simulator platform. The ultra realistic manikin-based simulator will be used to train medical professionals practising point of care ultrasound (PoCUS) across emergency medicine and critical care. First shown at the International Meeting on Simulation in Healthcare (IMSH) in Los Angeles last month and now launched for general … Continue reading MedaPhor launches ultrasound simulator

Paul Moraviec, the group chief executive of ConvaTec, has said the company had a “disappointing” overall performance in 2017, despite strong growth in a number of areas. Insider Media reports revenues at ConvaTec, which produces products to manage chronic conditions, grew by 4.5% in the 2017 calendar year to $1.76bn (£1.25bn). However the company’s operating … Continue reading ConvaTec posts “disappointing” performance

MedaPhor have announced the first pilot of its ScanNav real time image analysis software at the Foetal Medicine Department of St George’s University Hospitals NHS Trust. ScanNav is believed to be the first CE marked AI system to carry out an automated, real time “peer review” of obstetric ultrasound images as someone is scanned. Monitoring … Continue reading AI software to be piloted for pregnancy screening

First Minister Carwyn Jones has announced that Ortho Clinical Diagnostics will receive up to £960,000 in business finance funding from the Welsh Government that will help create forty nine new jobs. The Welsh Government reports the investment will help the company as it competes on a global stage, by increasing production capability at the Pencoed … Continue reading Ortho Clinical Diagnostics to create 49 jobs

TrakCel has announced a consortium including itself, the Cell and Gene Therapy Catapult, Rexgenero Ltd and Fisher Bioservices (part of Thermo Fisher Scientific) has secured funding of £1.4m from Innovate UK to lead an industrial research project. The project will focus on and design a cost effective commercial manufacturing strategy for Rexgenero’s novel autologous cell … Continue reading £1.4m awarded to commercialise Rexgenero cell therapy

Signum Health, a Welsh health start-up, has secured a £400,000 investment. WalesOnline reports Signum Health secured an equity co-investment led by the Development Bank of Wales, with further investment obtained from private investors. This was the second round of investment for the company, increasing the initial investment from £200,000. Signum Health also appointed the former … Continue reading Signum Health boosted by Development Bank of Wales

EKF Diagnostics is raising $25m (£17.6m) to float one of its divisions in the US, then use the funds to develop artificial intelligence tracking kidney disease. The Sunday Times reports EKF hopes the new company can help it secure deals with big hospital groups across the US. RenaltyxAI will mine data from medical records and … Continue reading EKF Diagnostics to float US division

Bridgend-based design and manufacturing company Pinpoint Scientific Limited have recently completed a proof of market study for novel microbiological air sampling technology. This work was partly funded by a grant from Innovate UK and has allowed Pinpoint to clearly understand the commercial opportunity and user requirements for a novel, isolator compatible microbial air monitor. Pinpoint … Continue reading Pinpoint awarded Innovate UK grant

BBI Solutions has announced the addition of over eighty new antibodies to its growing product portfolio, as well as custom antibody development services following the acquisition of Maine Biotechnology Services (MBS) in Portland, Maine. BBI, a leading manufacturer of raw materials and finished test platforms, already provides human antigens, antibodies, serum and plasma products and … Continue reading BBI Solutions acquires Maine Biotechnology Services

Celixir, a private company discovering and developing lifesaving regenerative medicines, has announced it has received formal clinical trial application (CTA) approval from the Medicines and Healthcare Products Regulatory Agency to initiate a Phase IIb human clinical trial with its Heartcel medicine for the treatment of moderate to severe adult heart failure. Heart failure affects over … Continue reading Celixir gets approval for potentially pivotal clinical trial